Healthcare - Biotechnology - NASDAQ - US
$ 3.22
-2.72 %
$ 272 M
Market Cap
-1.56
P/E
BALANCE SHEET
595 M
ASSETS
39.8 M
LIABILITIES
555 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Atea Pharmaceuticals, Inc.
| Current Assets | 590 M |
| Cash & Short-Term Investments | 578 M |
| Receivables | 0 |
| Other Current Assets | 12.3 M |
| Non-Current Assets | 4.51 M |
| Long-Term Investments | 0 |
| PP&E | 3.12 M |
| Other Non-Current Assets | 1.4 M |
| Current Liabilities | 32.4 M |
| Accounts Payable | 4.25 M |
| Short-Term Debt | 760 K |
| Other Current Liabilities | 27.4 M |
| Non-Current Liabilities | 7.4 M |
| Long-Term Debt | 1.64 M |
| Other Non-Current Liabilities | 5.76 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 143.8 | 646.7 | 764.4 | 850.1 | 21.7 | 34.5 |
| Short Term Investments | 434.3 | 458.2 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 5.8 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.3 | 14.2 | 16.1 | 15.1 | 0.2 | 0.2 |
| Total Current Assets | 590.5 | 660.9 | 772.4 | 863.5 | 21.9 | 34.7 |
| PP&E | 3.1 | 4.1 | 23 K | 48 K | 41 K | 56 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 |
| Other Long Term Assets | 1.4 | 1.5 | 0.2 | 0 | 15 K | 0 |
| Other Assets | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 595.0 | 666.7 | 772.9 | 863.6 | 22.1 | 34.9 |
| LIABILITIES | ||||||
| Accounts Payable | 4.3 | 2.6 | 4.5 | 60 K | 0.5 | 0.4 |
| Short Term Debt | 0.8 | 1.4 | 0.2 | 0 | 0 | 0 |
| Other Current Liabilities | 27.4 | 14.4 | 49.6 | 14.4 | 1.9 | 1.4 |
| Total Current Liabilities | 32.4 | 18.5 | 56.9 | 315.8 | 2.4 | 1.8 |
| Long Term Debt | 1.6 | 2.4 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 5.8 | 5.3 | 5.9 | 36 K | 69.2 | 69.3 |
| Total Liabilities | 39.8 | 26.1 | 62.8 | 315.8 | 71.6 | 71.0 |
| EQUITY | ||||||
| Common Stock | 83 K | 83 K | 83 K | 82 K | 10 K | 10 K |
| Retained Earnings | (195.8) | (59.9) | 56.0 | (65.2) | (54.2) | (40.2) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (0.7) | 0 | (863.6) | (69.1) | (69.1) |
| Total Equity | 555.2 | 640.6 | 710.1 | 547.8 | (49.6) | (36.2) |
| Total Liabilities and Equity | 595.0 | 666.7 | 772.9 | 863.6 | 22.1 | 34.9 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 83.4 | 83.2 | 82.8 | 82.4 | 82.6 | 47.3 |